Overview: Varicella Zoster IgM TestIntroduction: The Varicella Zoster IgM Test detects VZV IgM to diagnose recent chickenpox or shingles, causing rash. Following 2023 CDC guidelines, it uses immunoassays for high specificity, supporting infection screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in immunology for patients with suspected active VZV infection.
Other Names: VZV IgM Assay, Chickenpox Acute Infection Test.
FDA Status: Laboratory-developed test (LDT), meeting immunology standards for diagnostic accuracy.
Historical Milestone: VZV IgM testing began in the 1980s with viral infection research. Immunoassay methods improved in the 2000s, enhancing diagnostic precision.
Purpose: Detects VZV IgM to diagnose recent chickenpox or shingles, guides treatment, and evaluates patients with rash.
Test Parameters: 1. VZV IgM Antibodies
Pretest Condition: No fasting required. Collect serum or saliva. Report history of rash or VZV exposure.
Specimen: Serum (SST, 2-5 mL), Saliva (sterile container, 1-2 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document rash, fever, or history of VZV exposure. Include current medications, especially antivirals.
Consent: Written consent required, detailing the tests purpose, VZV infection implications, and risks of sample collection.
Procedural Considerations: Uses enzyme-linked immunosorbent assay (ELISA) to detect VZV IgM antibodies. Results are available in 1-2 days, supporting clinical decisions. Performed in laboratories, often for acute VZV diagnosis.
Factors Affecting Result Accuracy: Sample hemolysis or improper storage can affect results. Early infection may reduce sensitivity.
Clinical Significance: Positive VZV IgM confirms recent chickenpox or shingles, guiding antiviral therapy. Negative results may require PCR or repeat testing.
Specialist Consultation: Consult an infectious disease specialist for result interpretation and treatment planning.
Additional Supporting Tests: VZV PCR, IgG, or clinical evaluation to confirm active VZV infection.
Test Limitations: Non-specific for infection stage; clinical correlation is needed. Sample quality affects sensitivity.
References: CDC VZV Guidelines, 2023; Clinical Infectious Diseases, Gilden D, 2022.
